Catalyst Wire Dossier Catalyst Wire Dossier

Gene-Activated® Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy

glucocerebrosidase · Shire
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gene-Activated® Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy, covering 2010-09-10 to 2010-09-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Gaucher Disease [Phase 3]

See pricing